|
1
|
Lloyd RV, Osamura RY, Klöppel G and Rosai
J: WHO classification of tumours of endocrine organs. Lloyd RV,
Osamura RY, Klöppel G and Rosai J (eds). International Agency for
Research on Cancer, 2017.
|
|
2
|
Pillai S, Gopalan V, Smith RA and Lam AKY:
Updates on the genetics and the clinical impacts on
phaeochromocytoma and paraganglioma in the new era. Crit Rev Oncol
Hematol. 100:190–208. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gómez AM, Soares DC, Costa AAB, Pereira
DP, Achatz MI and Formiga MN: Pheochromocytoma and paraganglioma:
Implications of germline mutation investigation for treatment,
screening, and surveillance. Arch Endocrinol Metab. 63:369–375.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Seo SH, Kim JH, Kim MJ, Cho SI, Kim SJ,
Kang H, Shin CS, Park SS, Lee KE and Seong MW: Whole exome
sequencing identifies novel genetic alterations in patients with
pheochromocytoma/paraganglioma. Endocrinol Metab (Seoul).
35:909–917. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Farrugia FA and Charalampopoulos A:
Pheochromocytoma. Endocr Regul. 53:191–212. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Phillips RA, Manger WM and Gifford RW:
Pheochromocytoma. J Clin Hypertens. 4:62–72. 2002.
|
|
7
|
Carrasquillo JA, Chen CC, Jha A, Ling A,
Lin FI, Pryma DA and Pacak K: Imaging of pheochromocytoma and
paraganglioma. J Nucl Med. 62:1033–1042. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nölting S, Bechmann N, Taieb D, Beuschlein
F, Fassnacht M, Kroiss M, Eisenhofer G, Grossman A and Pacak K:
Personalized management of pheochromocytoma and paraganglioma.
Endocr Rev. 43:199–239. 2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Huang Y, Wang LA, Xie Q, Pang J, Wang L,
Yi Y, Zhang J, Zhang Y, Chen R, Lan W, et al: Germline SDHB and
SDHD mutations in pheochromocytoma and paraganglioma patients.
Endocr Connect. 7:1217–1225. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Negro A, Nicoli D, Cavazza A, Santi R,
Bonilauri S, Farnetti E and Panebianco M: A rare case of
carney-stratakis syndrome in a patient with SDHA mutation. J Med
Cases. 8:191–195. 2017.
|
|
11
|
Negro A, Graiani G, Nicoli D, Farnetti E,
Casali B, Verzicco I, Tedeschi S, Ghirarduzzi A, Cannone V, Marco
LDE, et al: Concurrent heterozygous Von-Hippel-Lindau and
transmembrane-protein-127 gene mutation causing an
erythropoietin-secreting pheochromocytoma in a normotensive patient
with severe erythrocytosis. J Hypertens. 38:340–346.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Adachi Y, Mita H, Sasaki Y, Himori R,
Onodera K, Nakamura M, Kikuchi T, Yamashita K, Yoshida Y, Ishii Y
and Endo T: Malignant paraganglioma of the posterior mediastinum: A
case report with genetic analysis. Mol Clin Oncol. 10:10–16.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sarkadi B, Liko I, Nyiro G, Igaz P, Butz H
and Patocs A: Analytical performance of NGS-based molecular genetic
tests used in the diagnostic workflow of
pheochromocytoma/paraganglioma. Cancers (Basel).
13(4219)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Landrum MJ, Lee JM, Benson M, Brown GR,
Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Jang W, et al:
ClinVar: Improving access to variant interpretations and supporting
evidence. Nucleic Acids Res. 46(D1062)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Rodrigues EDS, Griffith S, Martin R,
Antonescu C, Posey JE, Coban-Akdemir Z, Jhangiani SN, Doheny KF,
Lupski JR, Valle D, et al: Variant-level matching for diagnosis and
discovery: Challenges and opportunities. Hum Mutat.
43(782)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tate JG, Bamford S, Jubb HC, Sondka Z,
Beare DM, Bindal N, Boutselakis H, Cole CG, Creatore C, Dawson E,
et al: COSMIC: The catalogue of somatic mutations in cancer.
Nucleic Acids Res. 47:D941–D947. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Khalaf S, Jamal HF, Alawi ZS and Alsaeed
M: Bilateral pheochromocytoma and paraganglioma tumors due to von
hippel-lindau syndrome in a 15-year-old boy: A case report. Cureus.
15(e47787)2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rednam SP, Erez A, Druker H, Janeway KA,
Kamihara J, Kohlmann WK, Nathanson KL, States LJ, Tomlinson GE,
Villani A, et al: Von hippel-lindau and hereditary
pheochromocytoma/paraganglioma syndromes: Clinical features,
genetics, and surveillance recommendations in childhood. Clin
Cancer Res. 23:e68–e75. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gniado E, Carracher CP and Sharma S:
Simultaneous occurrence of germline mutations of SDHB and TP53 in a
patient with metastatic pheochromocytoma. J Clin Endocrinol Metab.
105:991–995. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lima JV Jr, Scalissi NM, de Oliveira KC,
Lindsey SC, Olivati C, Ferreira EN and Kater CE: Germline genetic
variants in pheochromocytoma/paraganglioma: Single-center
experience. Endocr Oncol. 3(e220091)2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nölting S, Ullrich M, Pietzsch J, Ziegler
CG, Eisenhofer G, Grossman A and Pacak K: Current management of
pheochromocytoma/paraganglioma: A guide for the practicing
clinician in the era of precision medicine. Cancers (Basel).
11(1505)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Taïeb D, Hicks RJ, Hindié E, Guillet BA,
Avram A, Ghedini P, Timmers HJ, Scott AT, Elojeimy S, Rubello D, et
al: European association of nuclear medicine practice
guideline/society of nuclear medicine and molecular imaging
procedure standard 2019 for radionuclide imaging of
phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging.
46:2112–2137. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Su TW, Zhong X, Ye L, Song W, Jiang L, Xie
J, Jiang Y, Zhou W, Zhang C, Wu L, et al: A nomogram for predicting
the presence of germline mutations in pheochromocytomas and
paragangliomas. Endocrine. 66:666–672. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sbardella E, Cranston T, Isidori AM, Shine
B, Pal A, Jafar-Mohammadi B, Sadler G, Mihai R and Grossman AB:
Routine genetic screening with a multi-gene panel in patients with
pheochromocytomas. Endocrine. 59:175–182. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sarkadi B, Liko I, Nyiro G, Igaz P, Butz H
and Patocs A: Analytical performance of ngs-based molecular genetic
tests used in the diagnostic workflow of
pheochromocytoma/paraganglioma. Cancers (Basel). 13:2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mellid S, Gil E, Letón R, Caleiras E,
Honrado E, Richter S, Palacios N, Lahera M, Galofré JC,
López-Fernández A, et al: Co-occurrence of mutations in NF1 and
other susceptibility genes in pheochromocytoma and paraganglioma.
Front Endocrinol (Lausanne). 13(1070074)2023.PubMed/NCBI View Article : Google Scholar
|
